Inventor

Mark Stuart Chambers

Inventor

Puckeridge, GB

Overview

1993–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 67 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds47%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%

A61KPreparations for medical, dental or toiletry purposes15%

C04BLime, magnesia1%

C07BGeneral methods of organic chemistry1%

C07CAcyclic or carbocyclic compounds1%

PatentTitleYear

10,538,530Vasopressin receptor antagonists and products and methods related thereto2020 10,214,509Amino-substituted heterocyclic derivatives as sodium channel inhibitors2019 10,130,619Amido thiadiazole derivatives as NADPH oxidase inhibitors2018 10,016,439Fused imidazole compounds2018 9,212,173'Pyrazole aminopyrimidine derivatives as LRRK2 modulators'2015 9,145,402'Aminopyrimidine derivatives as LRRK2 modulators'2015 9,006,237'Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases'2015 8,815,882'Pyrazole aminopyrimidine derivatives as LRRK2 modulators'2014 8,809,331'Aminopyrimidine derivatives as LRRK2 modulators'2014 8,802,674'Aminopyrimidine derivatives as LRRK2 modulators'2014 8,796,296'Aminopyrimidine derivatives as LRRK2 modulators'2014 8,791,130'Aminopyrimidine derivatives as LRRK2 modulators'2014 8,354,420'Aminopyrimidine derivatives as LRRK2 inhibitors'2013 8,178,530'Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases'2012 8,173,656'Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases'2012 8,148,369'Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases'2012 8,138,193'Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases'2012 8,133,895'Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases'2012 8,012,983'Substituted triazolopyrazines useful for the treatment of degenerative and inflammatory diseases'2011 7,915,256'Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases'2011 7,893,058'Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases'2011 7,592,456'Arylsulfonylnaphthalene derivatives as 5HT2A antagonists'2009 7,501,411'Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases'2009 7,482,457'Substituted quinoline-4-carboxylic hydrazides as NK-2/NK-3 receptor ligands'2009 7,271,191'Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of Alzheimer\'s disease'2007 7,176,203'Imidazo-triazine derivatives as ligands for gaba receptors'2007 7,153,868'N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists'2006 7,144,887'Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition'2006 7,094,777'5-HT2A receptor ligands'2006 7,030,128'Imidazo-pyrimidine derivatives as ligands for GABA receptors'2006 7,005,431'Imidazo-triazine derivatives as ligands for gaba receptors'2006 6,936,608'Imidazo-triazine derivatives as ligands for GABA receptors'2005 6,900,209'Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition'2005 6,900,215'Imidazo-pyrimidine derivatives as ligands for gaba receptors'2005 6,730,681'Triazolo-pyrimidine derivatives as ligands for gaba receptors'2004 6,638,930'Morpholine and thiomorpholine tachykinin receptor antagonists'2003 6,395,766'Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition'2002 6,395,905'Tetrahydroindazole derivatives as ligands for GABA-A 5 receptors'2002 6,355,638'Pyrazolo1,5-d1,2,4 triazines for enhancing cognition'2002 6,235,735'Morpholine and thiomorpholine tachykinin receptor antagonists'2001 6,156,787'Substituted thienlycyclohexanone derivatives for enhancing cognition'2000 6,156,761'Substituted tetralone derivatives for enhancing cognition'2000 6,143,773'Substituted thienobenzisoxazole derivatives for enhancing cognition'2000 6,048,859'Morpholine and thiomorpholine tachykinin receptor antagonists'2000 5,998,415'Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation, and their use of as selective agonists of 5-HT.sub.1 -like receptors'1999 5,981,529'Substituted indolylpropyl-piperazine derivatives as 5-HT.sub.1D .alpha. agonists'1999 5,973,156'Piperidine and tetrahydropyridine derivatives'1999 5,925,638'Substituted 1-indolylpropyl-4-benzylpiperazine derivatives'1999 5,919,783'Indoline and azaindoline derivatives as 5-HT.sub.1D alpha receptor agonists'1999 5,872,116'Morpholine and thiomorpholine tachykinin receptor antagonists'1999 5,854,268'Azetidine, pyrrolidine and piperidine derivatives'1998 5,849,746'Substituted 1,4-piperazine-heteroaryl derivatives as 5-HT.sub.1D receptor agonists'1998 5,807,857'Piperazine, piperidine and tetrahydropyridine derivative of indol-3-alkyl as 5-HT.sub.1D-.alpha. agonists'1998 5,719,147'Morpholine and thiomorpholine tachykinin receptor antagonists'1998 5,681,833'Benzodiazepine derivatives'1997 5,637,699'Process for preparing morpholine tachykinin receptor antagonists'1997 5,618,812'Benzodiazepine derivatives'1997 5,604,240'Pyrrolo-pyridine derivatives'1997 5,597,915'Benzodiazepine derivatives, compositions containing them and their use in therapy'1997 5,556,969'Benzodiazepine derivatives'1996 5,521,175'Benzodiazepine derivatives'1996 5,451,582'Benzodiazepine derivatives, compositions containing them and their use in therapy'1995 5,410,049'Benzodiazepine derivatives, compositions containing them and their use in therapy'1995 5,360,802'Benzodiazepine derivatives, compositions containing them and their use in therapy'1994 5,324,733'Spirocyclic antipsychotic agents'1994 5,219,860'Spirocyclic antipsychotic agents'1993 5,208,248'Indazole-substituted five-membered heteroaromatic compounds'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2009Patents assigned to MERCK SHARP & DOHME (32)· patent assignee history

1993–2003Based in Watford, GB· patent location history

1997–2015Based in Puckeridge, GB· patent location history

1998–1999Based in Ware, GB· patent location history

2009–2020Based in Saffron Walden, GB· patent location history

2011–2015Patents assigned to JANSSEN PHARMACEUTICA NV (7)· patent assignee history

2012–2015Patents assigned to ANDREWS MARTIN JAMES INGLIS (6)· patent assignee history

2012–2015Patents assigned to CHAMBERS MARK STUART (6)· patent assignee history

2012–2018Based in Essex, GB· patent location history

2013–2015Patents assigned to GENENTECH INC (8)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MERCK SHARP & DOHME	32	1993–2009
GENENTECH INC	8	2013–2015
JANSSEN PHARMACEUTICA NV	7	2011–2015
ANDREWS MARTIN JAMES INGLIS	6	2012–2015
CHAMBERS MARK STUARTself	6	2012–2015

Locations

Location	Patents	Span
Puckeridge, GB	33	1997–2015
Watford, GB	13	1993–2003
Saffron Walden, GB	11	2009–2020
Essex, GB	2	2012–2018
Ware, GB	2	1998–1999